Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 14351-14400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06621238
The Effect of Musıc on Labor Paın, Anxıety and Breastfeedıng Success
NA
Recruiting
140 participants
Started: Dec 7, 2024 · Completed: Apr 15, 2025
4 conditions
1 sponsor
1 location
NCT04679844
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
NA
Recruiting
60 participants
Started: Dec 6, 2024 · Completed: Aug 30, 2027
3 conditions
3 sponsors
4 locations
NCT06767488
Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors
N/A
Recruiting
375 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2026
4 conditions
1 sponsor
1 location
NCT06510491
Epcoritamab in Previously Treated WM
PHASE2
Recruiting
20 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
2 conditions
2 sponsors
3 locations
NCT06553235
RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention
NA
Recruiting
84 participants
Started: Dec 6, 2024 · Completed: Mar 28, 2030
3 conditions
2 sponsors
1 location
NCT06528171
Covid-19 Long Immunité IMagerie (CLIIM)
NA
Recruiting
200 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06706674
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
PHASE3
Recruiting
174 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
39 locations
NCT06540963
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
PHASE2
Recruiting
98 participants
Started: Dec 6, 2024 · Completed: Dec 1, 2035
1 condition
1 sponsor
3 locations
NCT06614491
SCOPE - Single-Point Classification Observational Peristomal Evaluation
N/A
Recruiting
600 participants
Started: Dec 6, 2024 · Completed: Jan 31, 2026
3 conditions
1 sponsor
3 locations
NCT06770634
Investigation of Central Sensitization and Associated Factors in Patients With Lipedema
N/A
Recruiting
50 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT06459791
Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
NA
Recruiting
110 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2028
1 condition
1 sponsor
3 locations
NCT06819293
IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma
PHASE1
Recruiting
12 participants
Started: Dec 6, 2024 · Completed: Dec 7, 2027
2 conditions
1 sponsor
1 location
NCT07003100
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
N/A
Recruiting
100 participants
Started: Dec 6, 2024 · Completed: Oct 19, 2026
9 conditions
2 sponsors
10 locations
NCT06678243
"Testing the mHealth App Intervention for Nondaily Smokers SiS4"
NA
Recruiting
1,600 participants
Started: Dec 6, 2024 · Completed: Jul 1, 2028
1 condition
3 sponsors
1 location
NCT06505447
PICU-related Sleep and Circadian Dysregulation Pilot Study
NA
Recruiting
30 participants
Started: Dec 6, 2024 · Completed: Jan 1, 2026
4 conditions
1 sponsor
1 location
NCT06465316
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
PHASE1
Recruiting
26 participants
Started: Dec 6, 2024 · Completed: Sep 16, 2026
2 conditions
1 sponsor
9 locations
NCT06381154
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
PHASE2
Recruiting
25 participants
Started: Dec 6, 2024 · Completed: Dec 6, 2029
6 conditions
2 sponsors
1 location
NCT06313437
Revumenib in Combination With 7+3 + Midostaurin in AML
PHASE1
Recruiting
22 participants
Started: Dec 6, 2024 · Completed: Mar 2, 2027
5 conditions
2 sponsors
2 locations
NCT06647225
Using Artificial Intelligence to Screen for Hip Dysplasia
NA
Recruiting
240 participants
Started: Dec 6, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06450210
Safety for Home Administration of Microdose Psilocybin Use
PHASE1
Recruiting
20 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06562283
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NA
Recruiting
80 participants
Started: Dec 6, 2024 · Completed: Oct 31, 2026
3 conditions
1 sponsor
4 locations
NCT06579404
Closed-loop in Adults With Type 2 Diabetes
NA
Recruiting
224 participants
Started: Dec 6, 2024 · Completed: Jul 31, 2027
1 condition
4 sponsors
12 locations
NCT06519682
A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
NA
Recruiting
20 participants
Started: Dec 6, 2024 · Completed: Aug 31, 2029
2 conditions
3 sponsors
1 location
NCT06609902
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
NA
Recruiting
70 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2028
2 conditions
1 sponsor
1 location
NCT06083480
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
PHASE4
Recruiting
148 participants
Started: Dec 6, 2024 · Completed: Mar 31, 2029
3 conditions
2 sponsors
1 location
NCT06855407
Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia
NA
Recruiting
30 participants
Started: Dec 6, 2024 · Completed: Jun 1, 2027
4 conditions
2 sponsors
1 location
NCT06654596
Efficacy and Safety of Telitacicept in IgAN
NA
Recruiting
118 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2026
4 conditions
12 sponsors
1 location
NCT06507072
Adaptive Rock Climbing
NA
Recruiting
20 participants
Started: Dec 6, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06826339
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
PHASE4
Recruiting
340 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
9 conditions
2 sponsors
1 location
NCT06681766
A Study to Assess Nomlabofusp in Adolescents and Children with Friedreich's Ataxia
PHASE1
Recruiting
30 participants
Started: Dec 6, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06686745
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
PHASE1
Recruiting
130 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2028
1 condition
2 sponsors
2 locations
NCT06716151
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
PHASE1
Recruiting
60 participants
Started: Dec 6, 2024 · Completed: Nov 20, 2025
1 condition
1 sponsor
1 location
NCT06701422
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
NA
Recruiting
36 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2026
3 conditions
1 sponsor
2 locations
NCT06728241
Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis
NA
Recruiting
150 participants
Started: Dec 6, 2024 · Completed: Jul 31, 2028
1 condition
1 sponsor
2 locations
NCT06888310
Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease
NA
Recruiting
408 participants
Started: Dec 6, 2024 · Completed: Mar 1, 2027
2 conditions
1 sponsor
1 location
NCT06757569
Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden
NA
Recruiting
160 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06878625
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
PHASE2
Recruiting
138 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT06725108
Hemodynamic ABI Monitor
N/A
Recruiting
50 participants
Started: Dec 6, 2024 · Completed: Dec 6, 2026
2 conditions
2 sponsors
1 location
NCT06773988
Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy
N/A
Recruiting
17 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06856525
Dissolved Phase HXe-129 MRI: a Novel Biomarker to Quantify Pulmonary Pathology in Young Healthy E-cigarette Users
PHASE2/PHASE3
Recruiting
80 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2032
1 condition
3 sponsors
2 locations
NCT06161285
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
N/A
Recruiting
120 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2026
1 condition
2 sponsors
3 locations
NCT06728332
An Observational Study to Learn More About How Menopause Affects Women's Sleep and How They Are Being Treated for Sleep Problems
N/A
Recruiting
1,000 participants
Started: Dec 6, 2024 · Completed: Oct 14, 2025
1 condition
1 sponsor
1 location
NCT05962229
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
PHASE1
Recruiting
18 participants
Started: Dec 6, 2024 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT06494904
Standard Versus High Dose ED-Initiated Buprenorphine Induction
PHASE3
Recruiting
360 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
1 condition
5 sponsors
5 locations
NCT06983327
Brief Intervention for Chronic Pain and History of Stressful Experiences
NA
Recruiting
50 participants
Started: Dec 6, 2024 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT06667908
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
PHASE2
Recruiting
130 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
23 locations
NCT06834932
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
PHASE2/PHASE3
Recruiting
300 participants
Started: Dec 6, 2024 · Completed: Jun 18, 2027
1 condition
1 sponsor
40 locations
NCT06735755
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
PHASE1/PHASE2
Recruiting
36 participants
Started: Dec 6, 2024 · Completed: Dec 30, 2027
1 condition
1 sponsor
2 locations
NCT06383247
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
NA
Recruiting
290 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT05964140
The MANTRA Trial (MANdibular TRauma and Antibiotic Use)
PHASE3
Recruiting
2,841 participants
Started: Dec 6, 2024 · Completed: Dec 31, 2027
2 conditions
1 sponsor
2 locations
Previous
1
More pages
285
286
287
288
289
290
291
More pages
1333
Next